Analysis of Revenues
Paying users area
Try for free
GlaxoSmithKline PLC pages available for free this week:
- Balance Sheet: Assets
- Cash Flow Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
The data is hidden behind: . Unhide it.
Get 1-month access to GlaxoSmithKline PLC for $22.49, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
GlaxoSmithKline PLC, income statement, revenues
US$ in millions, translated from GBP £
| 12 months ended: | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals and Vaccines | |||||||||||
| Consumer Healthcare turnover | |||||||||||
| Turnover by segment |
Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).
| Item | Description | The company |
|---|---|---|
| Turnover by segment | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | GlaxoSmithKline PLC turnover by segment increased from 2012 to 2013 but then decreased significantly from 2013 to 2014. |